Finally, one might envision applying a network pharmacology strategy to simultaneously target HES6 and/or other NOTCH-related targets, which may produce therapeutic synergistic effects and translate into better therapeutic efficacy in different cancers. This evidence concerns the gene HES6 and cancer.